AUG 2021

Portfolio Company Amplyx Pharmaceuticals Acquired by Pfizer


ST. LOUIS (August 26, 2021)

NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) announced today that it has acquired Amplyx Pharmaceuticals, Inc., a privately-held company dedicated to the development of therapies for debilitating and life-threatening diseases that affect people with compromised immune systems. Amplyx’s lead compound, Fosmanogepix (APX001), is a novel investigational asset under development for the treatment of invasive fungal infections.


© Copyright RiverVest® All Rights Reserved.